Innophos Reports Net Sales of $209 Million in Q4
date:Feb 16, 2013
$6 million above the year ago level on lower market prices, but higher volumes.

Diluted EPS for 2012 was $3.30 compared to $3.83 for 2011. The fourth quarter adjustment items noted above, together with earlier adjustments noted in prior quarters, amounted to $0.22 per share for full year 2012 and $0.02 per share for full year 2011. Giving effect to these adjustments, 2012 diluted EPS would have been $3.08 compared to $3.81 for 2011.

Randy Gress, CEO of Innophos, commented on the results, I am
4/11 next page prev page home page last page
go back |  refresh |  WAP home |  Web page version  | login
07/17 11:58